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license (http://creativecommons.org/Summary Articular chondrocytes are the main cell population in cartilage, and damage to
them is a key step in osteoarthritis. There are chondrocyte-based strategies to treat osteoar-
thritis, among which includes nonviral gene therapy. However, so far there is no ideal way to
achieve this because chondrocyte cells are very difficult to transfect. Also, an effective
tracking system to evaluate exogenous DNA delivery in chondrocytes is a necessary part of this
strategy. Here, we show our development of a novel tracking system by labelling cell mem-
branes, nuclei, and plasmids, without disturbing their expression, to view the intracellular
behaviour of plasmids before, after, and during the entire transfection process. We applied
this system to compare the intracellular behaviour of exogenous DNA in chondrocytes and can-
cer cells. We also used this system to compare the intracellular behaviour of exogenous DNA
which is transfected by liposomes or polymers. Finally, we discovered that when transfected
by liposomes, exogenous DNA has a quicker cell entry and nucleus entry in cancer cells than
in chondrocytes, and the transfection efficiency is higher in cancer cells than in chondrocytes.
When the cells are transfected by polymers, exogenous DNA has the same quick cell entry and
nucleus entry in both types of cells. However, the transfection efficiency was higher in cancer
cells than in chondrocytes. Applying this system has proved to be simple, easy to operate,
repeatable, and stable and it enables tracking of the behaviour of plasmid DNA before and af-
ter expression. Meanwhile, the rate-limiting zones of exogenous plasmid DNA in living cells and
a comprehensive overview of the expression and transfection efficiency of DNA can also bey Laboratory of Orthopaedic Implant, Department of Orthopaedic Surgery, Shanghai Ninth People’s
School of Medicine, Shanghai 200011, PR China.
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158 H. Tong et al.obtained through this system, making it ideal for the research and development of nonviral
DNA delivery systems.
Copyrightª 2014, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Rapid developments in molecular biology and biotech-
nology have facilitated the understanding of the mecha-
nisms of diseases at the molecular level, and
the identification of numerous disease-related genes
provides a broad potential for gene therapy. Gene therapy
has extensively investigated recuperating the shortage
of certain functional proteins [1,2], silencing the expres-
sion of existing genes [3,4], or producing prodrug-
activating enzymes [5]. However, the inadequacy of
safe, efficient, and controllable methods for gene delivery
remains a key limitation in the development of human
gene therapy. Considering the potential safety risks and
immunogenicity of viral vectors [6,7], the development of
alternative nonviral gene carriers is an urgent require-
ment [8].
In general, synthetic vectors are materials that elec-
trostatically bind with DNA, condense genetic material
into particles of a few tens to several hundred nanometres
in diameter, protect genes, and mediate cellular entry;
such complexes of plasmid DNA with polymers or cationic
lipids are known as polyplexes and lipoplexes, respec-
tively [9]. However, these vectors are not ideal due to
high toxicity or low efficacy to some special cell types
such as chondrocytes. To select ideal vectors from huge
amounts of chemicals, it is important to have an efficient
selection system. Usually, the selection processes are
constituted by two steps with the efficiency evaluation
first and then the tracking system to discover the rate-
limiting step. To improve the selection efficiency, we
tried to combine these two steps into one step by using
the Cy5 labelled EGFP expressing plasmid. Together with
the staining of the cell nucleus and membrane, it is a
more efficient way to select the vectors than the previous
setting. By doing so, it is also easier to keep the consis-
tency between experiments. Moreover, another advan-
tage of this system is its ability to track the plasmids after
their expression, which can provide important information
about their integration into the genome or exclusion to be
degraded.
To our knowledge, the final expression of exogenous
plasmid DNA entails several steps, including endocytosis,
escape from the endolysosome, trafficking through cyto-
plasm and the cytoskeleton, unpacking of complexes, and
importation into the nucleus. In this process, each step is
possibly the rate-limiting step [10,11]. According to the
area where the steps occur, these five steps can be ar-
ranged into three zones: extracellular matrix, cytoplasm,
and nucleus. If endocytosis is the rate-limiting step, the
membrane is the major obstacle to the complexes. If the
complexes stagnate in the cytoplasm, the next two stepsmay become the rate-limiting steps. The last two steps
involve two situations. In the first situation, unpacking of
the complex occurs before the nucleus import of the
plasmid, whereas in the other situation, the complex enters
the nucleus before it undergoes unpacking [12,13]. There-
fore, our tracking system can give a rough recognition of
the rate-limiting step of vectors based on the dynamic
location of the plasmids.
Because chondrocytes are very difficult to transfect, and
are also the important cell source for cell therapy or gene
therapy of cartilage dysfunction, we decided to use chon-
drocyte cell line C5.18 as a cell model to detect our novel
tracking system. Meanwhile, the HeLa cancer cell line was
used as a comparison control. We hope this novel tracking
system can serve as a good basis for the research and
development of nonviral DNA delivery vectors.
Materials and methods
Cells and vectors
The carcinoma cell line HeLa (CCL-2, ATCC) was cultured
in high-glucose Dulbecco’s modified Eagle’s medium
(Invitrogen, Carlsbad, CA, USA) with 10% foetal bovine
serum (FBS; Hyclone, Logan, Utah, USA), and incubated at
37C under 5% carbon dioxide (CO2). The chondrogenic
cell line C5.18 was cultured in a-modified Eagle’s minimal
essential medium (Invitrogen) with 10% FBS, and incu-
bated at 37C under 5% CO2. PEI25kDa (Sigma, St. Louis,
MO, USA) and Lipofectamine2000 (Invitrogen) are classic
representatives of cationic lipid and polymeric vectors,
respectively.
Labelling of plasmid DNA
The labelling of pEGFP-N1 (Invitrogen) with Cy5 (Label
IT Tracker Intracellular Nucleic Acid Localization Kit,
Mirus, Piscataway, NJ, USA) was performed according to
the manufacturer’s protocols. Briefly, 25 mL Cy5 solution
and 50 mg pEGFP-N1 solution were added into labelling
buffer to produce a total volume of 500 mL reaction sys-
tem. The solution was incubated at 37C for 1 hour.
Unreacted Cy5 was removed from the labelled plasmid by
ethanol precipitation. Then, 0.1 volume of 5 M sodium
chloride and 2 volumes of ice-cold 100% ethanol were
added to the reaction, and the solution was placed in a
freezer at 20C for at least 30 minutes. Subsequently, the
solution was centrifuged at full speed in a refrigerated
microcentrifuge for 10 minutes to pellet the labelled DNA.
The pellet was washed once with 70% ethanol at room
temperature and finally dissolved in sterile water. The
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light.
Complexation of nonviral gene vector with plasmid
DNA
The complexation of the nonviral gene vector PEI25kDa
with pEGFP-N1 (Invitrogen) was performed according to a
previously reported method [14]. In brief, 40 mL PEI25kDa
solution (0.0675 mg/mL) was added into 40 mL labelled
pEGFP-N1 (0.05 mg/mL) to make the N/P (polymer/DNA ni-
trogen/phosphate) Z 10 polyplexes solution, vortexed for
30 seconds, and then incubated for 30 minutes at room
temperature. The complexation of the nonviral gene vector
Lipofectamine2000 with pEGFP-N1 was conducted accord-
ing to the manufacturer’s protocols. Briefly, 4 mL Lip-
ofectamine2000 was diluted in 500 mL OptiMEM
(Invitrogen), and 2 mg labelled pEGFP-N1 was diluted in
500 mL OptiMEM. After 5 minutes of incubation at room
temperature, the diluted oligomer was gently mixed with
the diluted Lipofectamine2000. The mixture was then
incubated for 20 minutes at room temperature.
Transfection and tracking assay
The HeLa and C5.18 cells were seeded into 3-cm dishes
(Nest, Wuxi, China) at a density of 105 cells/mL/dish. After
24 hours of incubation, the cells were transfected with the
prepared complexes, the transfection medium was changed
by complete medium 4 hours post-transfection, and the
cells were cultured for another 20 hours. During this pro-
cess, the medium was discarded at different time points. At
the same time, the cell membrane was labelled with wheat
germ agglutinin (5 mg/mL, Invitrogen) and the nucleus was
labelled with Hoechst 33,342 (2 mg/mL, Invitrogen). After
the cells were washed, their photos were taken using aFigure 1 Intracellular imaging of the distribution and dynamics
nonviral gene vector PEI25kDa in living HeLa cells. (AeH) are diffe
30 minutes; (B) 2 hours; (C) 4 hours; (D) 8 hours; (E) 12 hours; (F) 1
images, the nucleus is grey, the cell membrane is red, the labelled
protein) is green. The images are the representative data of threelaser scanning confocal microscope (Leica SP5, Germany) at
63 magnification. The excitation and emission wave-
lengths were as follows: wheat germ agglutinin, 591 nm and
618 nm; Hoechst 33,342, 350 nm and 461 nm; Cy5, 649 nm
and 670 nm; and GFP, 488 nm and 509 nm. In each time
point, three photos were taken in different visions and
statistically analysed as shown in Figs. 3 and 6.
When taking the real-time video, the cells were pre-
stained by wheat germ agglutinin (5 mg/mL) and Hoechst
33,342 (2 mg/mL), and then transfected by the labelled
lipoplexes. During the first 4 hours, one image was taken
every 1 minute using a video camera, with images pre-
sented at 12 fps (frames per second). This experiment was
repeated three times. The representative video and related
data are displayed in a Supplementary Video and Fig. 7.
Supplementary data related to this article can be found
online at http://dx.doi.org/10.1016/j.jot.2014.06.001.
Statistical analysis
Analysis of variance and the Student t test were used for
statistical analysis, and p < 0.05 was considered significant.
Results
Cationic liposomal and polymeric vectors are commonly
used nonviral vectors. The use of cationic lipids for gene
delivery was first reported by Felgner [15] in 1987. Because
of their relatively high efficiency, cationic lipids have been
the most widely studied nonviral vectors. Lipofection has
been routinely used in in vitro and in vivo gene delivery
studies, and many physicochemical parameters such as
morphology, particle size, zeta potential, polymer/DNA
ratio, etc., have been proved to be related to the trans-
fection efficiency [16,17]. Polyethylenimine (PEI), one ofof exogenous pEGFP-N1 during the process of transfection by
rent confocal images captured according to the timeline: (A)
6 hours; (G) 20 hours; (H) 24 hours after transfection. In these
plasmid pEGFP-N1 is blue, and the product of pEGFP-N1 (GFP
photos in three different experiments.
Figure 2 Intracellular imaging of the distribution and dynamics of exogenous pEGFP-N1 during the process of transfection by
nonviral gene vector Lipofectamine2000 in living HeLa cells. (AeH) are different confocal images captured according to the
timeline: (A) 30 minutes; (B) 2 hours; (C) 4 hours; (D) 8 hours; (E) 12 hours; (F) 16 hours; (G) 20 hours; (H) 24 hours after trans-
fection. In these images, the nucleus is grey, the cell membrane is red, the labelled plasmid pEGFP-N1 is blue, and the product of
pEGFP-N1 (GFP protein) is green. The images are the representative data of three photos in three different experiments.
160 H. Tong et al.the most effective gene-delivery polymers studied to date,
has been used as a gene-delivery vector since 1995 [18]. It
has yielded successful results in in vivo gene delivery to a
variety of tissues. To set up our novel tracking system, we
chose PEI25kDa and Lipofectamine2000 as representatives
of polymeric and cationic liposomal vectors to detect the
intracellular behaviour of the plasmids pEGFP-N1 during
their in vitro transfection in HeLa and C5.18 cells. A
transfection friendly cancer cell line HeLa and a less
transfection friendly chondrocyte cell line C5.18 were used
as the cell models to test our novel tracking system.
Based on the confocal results, both PEI25kDa and Lip-
ofectamine2000 can mediate rapid endocytosis, nucleus
entry, and expression of exogenous plasmid in HeLa cells.Figure 3 Quantification of the percentages of HeLa cells that h
fection by PEI25 kDa and Lipofectamine2000, respectively. The per
and 2 according to the ratios of the cells that had labelled plasmid
calculated based on three photos in each time point (n Z 3). *p <According to Figs. 1 and 3, the ratio of the cells that had
labelled plasmids in cytoplasm was almost 100% at 30 mi-
nutes post-transfection by PEI25kDa, and in the following
24 hours, this ratio was very stable and remained over 80%.
The same kinetics were also observed in HeLa cells that had
been transfected by Lipofectamine2000 according to the
results of Figs. 2 and 3. Here, both PEI25kDa and Lip-
ofectamine2000 had rapid nucleus entry because the ratios
of the cells that had labelled plasmids in the nucleus at
30 minutes post-transfection were 52% and 43%, respec-
tively. As time went on, the ratio of PEI25kDa went down at
12 hours post-transfection, whereas the ratio of Lipofect-
amine2000 stayed relatively stable (Fig. 3). In general, the
kinetics of the plasmids transfected by PEI25kDa andad labelled plasmids in the cytoplasm or nucleus after trans-
centages were quantified using the images displayed in Figs. 1
s (blue) in the cytoplasm or nucleus (grey). The statistics were
0.05.
Figure 4 Intracellular imaging of the distribution and dynamics of exogenous pEGFP-N1 during the process of transfection by
nonviral gene vector PEI25 kDa in living C5.18 cells. (AeH) are different confocal images captured according to the timeline: (A)
30 minutes; (B) 2 hours; (C) 4 hours; (D) 8 hours; (E) 12 hours; (F) 16 hours; (G) 20 hours; (H) 24 hours after transfection. In these
images, the nucleus is grey, the cell membrane is red, the labelled plasmid pEGFP-N1 is blue, and the product of pEGFP-N1 (GFP
protein) is green. The images are the representative data of three photos in three different experiments.
A novel in vitro system for intracellular delivery 161Lipofectamine2000 were very similar in HeLa cells within
8 hours post-transfection. However, there is one issue that
needs to be addresse. Based on the results, we can roughly
speculate that PEI25kDa/pEGFP-N1 complexes show slower
unpacking rates than Lipofectamine2000/pEGFP-N1 com-
plexes in HeLa cells. By comparing the results in Figs. 1 and
2, the expression of pEGFP-N1 occurred 2 hours earlier in
the Lipofectamine2000 group than in the PEI25kDa group,
whereas the percentage of the cells that had plasmids in
the nucleus in the PEI25kDa group was almost the same as
that of that in the Lipofectamine2000 group at 30 minutes
post-transfection. If the unpacking rate of PEI25kDa/Figure 5 Intracellular imaging of the distribution and dynamics
nonviral gene vector Lipofectamine2000 in living C5.18 cells. (Ae
timeline: (A) 30 minutes; (B) 2 hours; (C) 4 hours; (D) 8 hours; (E)
fection. In these images, the nucleus is grey, the cell membrane is
pEGFP-N1 (GFP protein) is green. The images are the representativpEGFP-N1 complexes is the same as that of
Lipofectamine2000/pEGFP-N1 complexes, then the per-
centage and the appearance of GFP positive cells in the
PEI25kDa group should be higher and earlier than those in
the Lipofectamine2000 group. This analysis provides us with
a rough idea that the rate-limiting step of the transfection
vector of PEI25kDa in HeLa cells is the unpacking of
complexes.
The difference between the kinetics of PEI25kDa and
Lipofectamine2000 was more obviously observed in
C5.18 cells. PEI25kDa still had rapid delivery of pEGFP-N1 to
the cytoplasm and nucleus. At 30 minutes post-of exogenous pEGFP-N1 during the process of transfection by
H) are different confocal images captured according to the
12 hours; (F) 16 hours; (G) 20 hours; (H) 24 hours after trans-
red, the labelled plasmid pEGFP-N1 is blue, and the product of
e data of three photos in three different experiments.
Figure 6 Quantification of the percentages of C5.18 cells that had labelled plasmids in the cytoplasm or nucleus after trans-
fection by PEI25kDa and Lipofectamine2000, respectively. The percentages were quantified using the images displayed in Figs. 4
and 5 according to the ratios of the cells that had labelled plasmids (blue) in the cytoplasm or nucleus (grey). The statistics were
calculated based on three photos in each time point (n Z 3). *p < 0.05.
162 H. Tong et al.transfection, almost 100% of the cells had plasmids in their
cytoplasm, and nearly 50% of the cells had plasmids in their
nuclei (Figs. 4 and 6). However, Lipofectamine2000 deliv-
ered pEGFP-N1 into the C5.18 cells more slowly than
PEI25kDa did. Even at 4 hours post-transfection, most of
the plasmids remained outside the cells or attached to the
cell membranes, and only a small part of the plasmids had
entered into the cytoplasm. Moreover, only 18% of the cells
had plasmids in their nuclei (Figs. 5 and 6). However, the
expressions of pEGFP-N1 in these two groups similarly
started at 8 hours post-transfection, which again indicates
that the unpacking of PEI25kDa/pEGFP-N1 complexes mayFigure 7 Fluorescent densities of different dyes in the tracking s
HeLa cells were stained by wheat germ agglutinin (red) and Hoech
(blue) labelled plasmid using Lipofectamine2000. The video was tak
the representative values of the fluorescent densities of each dye u
the middle curve is for the membrane, and the lower curve is for th
experiments.be the rate-limiting step of PEI25kDa to transfect
C5.18 cells. The slow unpacking kinetic of PEI25kDa is very
similar to that revealed in a previous report [13]. The
reason for the quicker entry of plasmids into cytoplasm by
the transfection of PEI25kDa is probably due to the
involvement of the clathrin-independent mechanism which
is quicker than the clathrin-dependent mechanism [19].
Based on the results, we can also speculate that the rate-
limiting step of Lipofectamine2000 to transfect
C5.18 cells is the cell entry step.
To observe the kinetics in a real-time manner, we also
applied the real-time confocal in our tracking system. Inystem during the first 4 hours of transfection of HeLa cells. The
st 33342 (grey) first, and then immediately transfected by Cy5
en during the first 4 hours of transfection. The three curves are
sed in the tracking system. The upper curve is for the plasmid,
e nucleus. This is the representative data of three independent
A novel in vitro system for intracellular delivery 163the video (Supplementary Video 1), we can clearly observe
the movement of Cy5-labelled plasmid from the extracel-
lular into the intracellular compartment. We also measured
the signal density from the labelled plasmid, cell mem-
brane, and nucleus from time to time (Fig. 7). The signals
were quite stable in our tracking system at least 4 hours
post-transfection, which ensures that our tracking system is
applicable for real-time confocal.Discussion
Based on the results of this study, our novel tracking system
has several advantages. First, the method used to label the
plasmids is simple and does not disturb the expression of
exogenous plasmids. By contrast, the commonly used quan-
tum dot (QD) method is relatively time-consuming and
expensive, although this recently developed labelling
method has its own advantages. QD labelling entails two
steps, i.e., the initial biotinylation of plasmids followed by
the conjugation of streptavidin quantum dot. However these
steps result in the disturbance of plasmid expression [20].
Second, as it combines the general two-steps selection pro-
cess into one step, our tracking system can save both labour
and time. Moreover, the results will be more consistent than
the results from two steps. Third, the intracellular move-
ment of plasmids after their expression can also be analysed
in our tracking system,which is an additional benefit. Prior to
the present work, little attention was focused on the intra-
cellular behaviour of plasmids after their expression.
Research on the intracellular behaviour of plasmids after
expression can also provide some important information
which could be related to the expression duration and effi-
ciency of stable transfection. Whether the plasmids remain
in the cytoplasm ormove outside the cell may also be related
to cytotoxicity. Based on our results, the behaviours of the
plasmids transected by PEI25kDa inHeLa cells andC5.18 cells
are different after their expression. The ratio of the cells
which contain plasmids remained stable in C5.18 cells,
whereas this ratio decreased in HeLa cells after their
expression (Figs. 3 and 6). One possible explanation could be
that HeLa cells lose more plasmids through their more active
proliferation than C5.18 cells. Although the details of the
mechanism of how the plasmids exit from nuclei need to be
further investigated, this system provides a powerful tool to
undertake such research.
Although substantial information can be obtained
through the proposed system, it is still limited because the
mechanism of transfection is too complicated to be eluci-
dated by only one tracking system. Combining it with other
systems should result in a clearer understanding of the
mechanism of nonviral gene transfection. For example, the
lysosomes and cytoskeleton can be stained by other specific
dyes to investigate the rate-limiting step in the cytoplasm.
Low temperatures can be used to inhibit the endocytosis of
cell membranes and investigate the extracellular rate-
limiting step [21]. QD-fluorescence resonance energy
transfer technique can be used to evaluate the intracellular
stability and unpacking of the Nano complexes [22].
Another issue that should be mentioned is the limitation of
the confocal, as this technology can only scan the situation
of one layer of the cell and is unable to display the realsituation in the other layers. To accurately quantify the
percentage of the cells that had plasmids in the cytoplasm
or nuclei, we need the aid of flow cytometry technique and
organelle separation technique. Although additional studies
have to be conducted to fully discover the mechanism of
plasmid transfection by different kinds of nonviral vectors,
this proposed system could be a powerful preselection step.
As chondrocytes play important roles in degenerative
cartilage disorders such as osteoarthritis [23], they are oneof
the main cell sources used for cell therapy and gene therapy
of osteoarthritis. As our tracking system works well on the
chondrocyte cell line C5.18, it could be applied for some
rough preselection of vectors for chondrocyte transfection.Conclusion
We developed this novel tracking system by the reasonable
and efficient integration of several common techniques
presently used in cell biology, including the labelling of
plasmids and organelles and confocal imaging technique.
The novel integration enables these common techniques to
track the intracellular behaviour of plasmid DNA behaviour
before and after expression, and the determination of the
rate-limiting zones of exogenous plasmid DNA in living cells.
A comprehensive overview of the expression and trans-
fection efficiency of DNA can also be obtained simulta-
neously. By applying this tracking system, we can find the
rate-limiting step of PEI25kDa and lipofetamine2000 when
they transfect HeLa cells and C5.18 cells. In C5.18 cells, the
major rate-limiting step of PEI25kDa could be the unpack-
ing of complexes, while the major rate-limiting step of
Lipofectamine2000 could be cell entry. This simple, easy to
operate, repeatable, and stable system could be useful for
the preselection of nonviral vectors for gene delivery of
target cells such as chondrocytes, which will help to pro-
mote nonviral gene therapy to clinical interventions of
some difficult diseases such as cartilage disorder.Acknowledgements
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